The Variability of Platelet-Collagen Interaction. Its Influence on Aspirin-Induced Inhibition of Platelet Aggregation

Summary

A study of platelet aggregation induced by progressive concentrations of collagen was performed in 40 normal persons, equally grouped by sex, immediately before, and 90 min after, the ingestion of 0.500 g aspirin. Simultaneously, serum ASA-esterase activity and plasmatic salicylic acid levels were investigated in the pre- and post-ASA samples respectively. Wide individual variations in platelet responsiveness to collagen were found when the minimal amount of the aggregating agent necessary to provoke significant aggregation was located. The percentage of aggregation and the slope were the most sensible indicators of both the individual variances and the ASA-induced inhibition. Correlation was found in both groups between the minimal amounts of collagen required for initiating aggregation pre- and post-ASA. Also a positive correlation was found between the minimal collagen concentration required to initiate aggregation pre-ASA and the aspirin-induced inhibition in the aggregation produced by a higher collagen concentration. Important individual and sexual differences were detected in the serum content of ASA-esterase activity. A negative significant correlation was demonstrated between the ASA-esterase activity and the differences in collagen concentrations necessary to start aggregation pre- and post-aspirin in the men group. Failure to consider individual variances in platelet reactivity may lead to false conclusions about the ASA affective-ness as an antithrombotic agent.

• References

• 1 Al-Mondhiry H, Marcus A. J, Spaet T. H. 1970; On the mechanism of platelet function inhibition by acetylsalicylic acid. Proceedings of the Society for Experimental Biology and Medicine 133: 632.
• 2 Bonneau B, Bierme R, Boneau A, Guiraud B, Rascol A. 1972; Renouvellement plaquet-taire et durée d’inhibition de la deuxiéme vague d’aggrégation aprés prise unique d’aspirine. Pathologie-Biologie 20 Supplementum 71.
• 3 Brodie B. B, Udenfriend S, Coburn A. F. 1944; The determination of salicylic acid in plasma. Journal of Pharmacology and Experimental Therapeutics 80: 114.
• 4 Carvalho A. C. A, Colman R. W, Lees R. S. 1974; Platelet function in hyperlipoproteinemia. The New England Journal of Medicine 290: 434.
• 5 Danta G. 1973; Platelet aggregation in patients with cerebral vascular disease and in control subjects. Thrombosis et Diathesis Haemorrhagica 29: 730.
• 6 Green O, Dunne B, Schmidt F. R, Rossi E. C, Louis G. 1973; A study of the variable response of human platelets to collagen: Relation to aspirin-induced inhibition of aggregation. American Journal of Clinical Pathology 60: 920.
• 7 Hampton J. R, Mitchell J. R. A. 1974; Platelet electrophoresis: the present position. Thrombosis et Diathesis Haemorrhagica 31: 204.
• 8 Harker L. A, Slichter S. J. 1974; Arterial and venous thromboembolism. Kinetic characterization and evaluation of therapy. Thrombosis et Diathesis Haemorrhagica 31: 188.
• 9 Hirsh J, Street D, Cade J. F, Amy H. 1973; Relation between bleeding time and platelet connective tissue reaction after aspirin. Blood 41: 369.
• 10 Menguy R, Desbaillets L, Masters G. F, Okabe S. 1972; a Evidence for a sex-linked difference in aspirin metabolism. Nature 239: 102.
• 11 Menguy R, Desbaillets L, Okabe S, Masters G. F. 1972; b Abnormal aspirin metabolism in patients with cirrhosis and its possible relationship to bleeding in cirrhotics. Annals of Surgery 176: 412.
• 12 Mielke, Jr. Ramos J. S, Britten A. F. H. 1973; Aspirin as an antiplatelet agent: Template bleeding time as a monitor of therapy. American Journal of Clinical Pathology 59: 236.
• 13 Mills D. S, Sorda I. J, Philp R. B, Eldridge C. 1974; Effect of in vitro aspirin on blood platelets of gastrointestinal bleeders. Clinical Pharmacology and Therapeutics 15: 187.
• 14 Morgan A. M, Truitt Jr. E. B. 1965; Evaluation of acetylsalicylic acid esterase in aspirin metabolism. Interspecies comparison. Journal of Pharmaceutical Sciences 54: 1640.
• 15 Mustard J. F, Packham M. A. 1970; Factors influencing platelet function: adhesion, release and aggregation. Pharmacological Reviews 29: 97.
• 16 O’Brien J. R. 1968; Effects of salicylates on human platelets. The Lancet 1: 779.
• 17 O’Brien J. R, Tulevski V, Etherington M. 1971; Two in vivo studies comparing high and low aspirin dosage. The Lancet 1: 399.
• 18 Praga C, Malisardi P, Pollini C, Cortellaro M, Mars G. 1973; Bleeding time and antiag-gregating drugs: a controlled study in elderly patients. Thrombosis Research 3: 13.
• 19 Rowland M, Riegelman S. 1968; Pharmacokinetics of acetylsalicylic acid and salicylic acid after intravenous administration in man. Journal of Pharmaceutical Sciences, 57: 1313.
• 20 Sack E. S, Glanczpigel R. 1970. Efecto “in vivo” de la aspirina sobre la agregación plaquetaria. XV Reunión de la Sociedad Argentina de Investigación Clinica; Chapadmalal: p. 68.
• 21 Sack E. S, Glanczpigel R. 1972; Studies on the blood platelets release reaction. I Acid phosphatase availability. Medicina 30: 373.
• 22 Schwartz H. J. Bennett 1973; The differential effect of acetylsalicylic acid on in vitro aggregation of platelets from normal, asthmatic and aspirin-sensitive subjects. International Archives of Allergy 45: 899.
• 23 Spaet T. H, Zucker M. S. 1964; Mechanism of platelet plug formation and role of adenosine diphosphate. American Journal of Physiology 206: 1267.
• 24 Weiss H. J, Aledort L. M, Kochwa S. 1968; The effect of salicylates on the hemostatic properties of platelets in men. The Journal of Clinical Investigation 47: 2198.
• 25 Windorfer Jr. A, Kuenzer W, Urbaneck R. 1974; The influence of age on the activity of acetylsalicylic-acid-esterase and protein-salicylate binding. European Journal of Clinical Pharmacology 7: 227.
• 26 Yamazaki H, Numano F, Numano G, Shimamoto T. 1972; /73 Estrogen and hyperaggregability of platelets measured by the screen filtration pressure (SFP) method in Takayasu’s disease. Haemostasis 1: 285.
• 27 Zucker M. B. O. Borelli 1962; Platelet clumping produced by connective tissue suspensions and by collagen. Proceedings of the Society of Experimental Biology and Medicine 109: 779.